Cand.scient. Aslaug Aamodt Muggerud from Anne-Lise Børresen-Dale's group at the Department of Genetics at the Institute for Cancer Research gave her trial lecture on the subject "Clinical utility of genetic and epigenetic markers in the management of cancer. Current status" on Friday November 13th at 10.30.
She defends her PhD thesis - entitled "Genetic and epigenetic alterations in breast tumour progression: The transition from in situ to invasive cancer" on Friday November 13th at 13.15.
Venue for both events: Auditorium U1, The Norwegian Radium Hospital at Montebello.
From major journals, first or last author from the Institute for Cancer Research
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler
Cancers (Basel), 13 (17)
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
Nat Commun, 12 (1), 5307
Towards evidence-based personalised precision medicine for Lynch syndrome
Lancet Oncol, 22 (9), e383